Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Optima Medical Innovations Corp TOKID


Primary Symbol: TOKIF

Healthcare
Optima Medical Innovations Corp. is a Canada-based multidisciplinary pain management with the focus on mental health and wellness. The Company is focused on offering medicine in individualized and targeted treatments. It is also engaged in the development of focused solutions, products and treatments for pain relief, wellness, and cancer. The Company's consumer products include Miraqell Immune Mushroom, Miraqell Day Cream, Miraqell Cleanser and Miraqell Eye Serum.


GREY:TOKIF - Post by User

Optima Medical Innovations Corp
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(74)
•••
Post by Itdontmatteron Apr 24, 2020 12:31pm
127 Views
Post# 30949990

re: TOKI

re: TOKIOh well, so much for my theory !!!
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities